LETTER
AIDS Clinical Trials Group Study Numbers
C. Fordham von Reyn, MD
1 September 1995 | Volume 123 Issue 5 | Page 395
TO THE EDITOR:
The article by Fischl and colleagues [1] was useful. However, as with most other AIDS Clinical Trials Group (ACTG) studies you and others have published, it lacked any reference to the ACTG study number. Among AIDS clinicians and in future citations, this study will usually be referred to as the ACTG 155 study, but the unfortunate reader will be unable to find this information in the article itself. The ACTG numbers should be published ACTG studies.
|
Author and Article Information
|
|---|
Dartmouth-Hitchock Medical Center; Lebanon, NH 03756
1. Fischi MA, Stanley K, Collier AC, Ardunio JM, Stein DS, Feinberg JE, et al. Combination and monotherapy with zodovudine and zalcitabine in patients with advanced HIV disease. Ann Intern Med. 1995; 122:24-32.
About Letters
The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:
•Include no more than 300 words of text, three authors, and five references
•Type with double-spacing
•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.
Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.
Annals welcomes electronically submitted letters.
Top
Author & Article Info
References
Article
